Philip Ashton-Rickardt
Chief Tech/Sci/R&D Officer at SIGILON THERAPEUTICS, INC.
Net worth: - $ as of 30/07/2023
Philip Ashton-Rickardt active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SIGILON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 13/06/2021 | - |
Career history of Philip Ashton-Rickardt
Former positions of Philip Ashton-Rickardt
| Companies | Position | Start | End |
|---|---|---|---|
AZTherapies, Inc.
 AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | Corporate Officer/Principal | 31/12/2018 | 31/05/2021 |
Smith Therapeutics, Inc.
 Smith Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Smith Therapeutics, Inc. operates as a biopharmaceutical firm which treats neurodegenerative disease. The company was founded by Philip Ashton-Rickardt in 2017 and is headquartered in Chestnut, MA. | Director/Board Member | 31/12/2016 | 30/10/2019 |
| Chief Executive Officer | 31/12/2016 | 30/10/2019 | |
| Founder | 31/12/2016 | 30/10/2019 | |
| President | 31/12/2016 | 30/10/2019 | |
| Corporate Secretary | 31/12/2016 | 30/10/2019 | |
| The University of Chicago | Corporate Officer/Principal | 31/05/1995 | 31/05/2006 |
| Imperial College London | Corporate Officer/Principal | - | - |
Training of Philip Ashton-Rickardt
| King's College London | Undergraduate Degree |
| The University of Edinburgh | Doctorate Degree |
Statistics
International
| United States | 5 |
| United Kingdom | 4 |
Operational
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Consumer Services | 5 |
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Smith Therapeutics, Inc.
Smith Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Smith Therapeutics, Inc. operates as a biopharmaceutical firm which treats neurodegenerative disease. The company was founded by Philip Ashton-Rickardt in 2017 and is headquartered in Chestnut, MA. | Health Technology |
AZTherapies, Inc.
AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | Health Technology |
